AI Assistant
Blog
Pricing
Log In
Sign Up
Bortezomib provides favorable efficacy in type 3 acquired von willebrand syndrome related to lymphoplasmacytic lymphoma/Waldenstrom’s macroglobulinemia
Details
Cite
Export
Add to List
This content is not available in your region!
Continue researching
here.
